From the Journals

In and out surgeries become the norm during pandemic


 

Case studies in nephrectomy

While several case studies have looked at the feasibility and safety of performing partial and radical nephrectomy with same-day discharge in select cases, “this topic has not been addressed on a national level,” Mr. Garden said.

Few patients who have partial or radical nephrectomies have same-day discharges. The researchers found that fewer than 1% of patients who have either procedure in the sample studied were discharged the same day.

Researchers used the American College of Surgeons National Surgical Quality Improvement Program (NSQIP) database, a nationally representative deidentified database that prospectively tracks patient characteristics and 30-day perioperative outcomes for major inpatient and outpatient surgical procedures at more than 700 hospitals.

They extracted all minimally invasive partial and radical nephrectomies from 2012 to 2019 and refined the cohort to 28,140 patients who were theoretically eligible for same-day discharge: Of those, 237 (0.8%) had SSD, and 27,903 (99.2%) had a standard-length discharge (SLD).

The team found that there were no differences in 30-day complications or readmissions between same-day discharge (Clavien-Dindo [CD] I/II, 4.22%; CD III, 0%; CD IV, 1.27%; readmission, 4.64%); and SLD (CD I/II, 4.11%; CD III, 0.95%; CD IV, 0.79%; readmission, 3.90%; all P > .05).

Controlling for demographic and clinical variables, SDD was not associated with greater risk of 30-day complications or readmissions (CD I/II: odds ratio, 1.08; 95% confidence interval, 0.57-2.048; P = .813; CD IV: OR 1.699; 95% CI, 0.537-5.375; P = .367; readmission: OR, 1.254; 95% CI, 0.681-2.31; P = .467).

Mr. Garden and coauthors report no relevant financial relationships.

Dr. Lane reports no relevant financial relationships.

Pages

Recommended Reading

First robot for supermicrosurgery, used for lymphedema
MDedge Surgery
How is oncology adapting to COVID-19?
MDedge Surgery
Cancer care and COVID-19 in Seattle, the first U.S. epicenter
MDedge Surgery
Perspective from the heartland: Cancer care and research during a public health crisis
MDedge Surgery
Guidelines on delaying cancer surgery during COVID-19
MDedge Surgery
No staff COVID-19 diagnoses after plan at Chinese cancer center
MDedge Surgery
Advice from the front lines: How cancer centers can cope with COVID-19
MDedge Surgery
Antitumor treatment may increase risk of severe events in COVID-19 patients
MDedge Surgery
Call for a move or boycott of big Texas cancer meeting
MDedge Surgery
No advantages to using ADM in implant-based breast reconstruction
MDedge Surgery